ZDHHC23 Activators
ZDHHC23 Activators are a diverse group of chemical compounds that indirectly influence the functional activity of ZDHHC23, primarily through modulation of lipid metabolism and substrate availability for its palmitoylation activity. Palmitoyl Coenzyme A and 2-Bromopalmitate directly engage with ZDHHC23's substrate utilization: while Palmitoyl Coenzyme A serves as a direct substrate enhancing palmitoylation activity, 2-Bromopalmitate competes with natural substrates, potentially increasing ZDHHC23's substrate specificity. Curcumin and Fumonisin B1, through their respective impacts on lipid modification pathways and ceramide synthase inhibition, indirectly enhance ZDHHC23's activity by altering the balance of palmitoylation processes. Myriocin and Cerulenin, by inhibiting key enzymes in sphingolipid and fatty acid synthesis, further contribute to this modulation, potentially increasing the availability of ZDHHC23's palmitoylation substrates. This enhanced availability of substrates and altered lipid signaling cascades facilitate ZDHHC23's role in protein S-acylation, a post-translational modification crucial for membrane localization and protein interactions.
Additional compounds like Simvastatin, Fenofibrate, GW4869, Triacsin C, Nicotinamide, and Metformin extend this regulatory effect on ZDHHC23. Simvastatin and Fenofibrate, through their actions on cholesterol and lipid metabolism, respectively, modify the lipid environment in which ZDHHC23 operates, potentially enhancing its palmitoylation efficiency. GW4869 and Triacsin C, by altering sphingolipid metabolism and inhibiting acyl-CoA synthetase, respectively, influence the availability of essential components for ZDHHC23's enzymatic activity. Nicotinamide, affecting cellular energy states, and Metformin, known for its role in glucose metabolism, indirectly contribute to the optimal functional environment for ZDHHC23. These activators, through their collective impact on lipid metabolism and substrate availability, enhance the functional capacity of ZDHHC23 in protein palmitoylation, highlighting the intricate interplay between lipid metabolism and post-translational modification processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin influences various signaling pathways, including those involved in lipid metabolism and modification. It can indirectly enhance ZDHHC23 activity by altering the cellular balance of palmitoylation, thus impacting ZDHHC23-mediated processes. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, which can lead to altered sphingolipid metabolism. This alteration indirectly affects the substrate availability for ZDHHC23, potentially enhancing its palmitoylation activity. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
Myriocin is a potent inhibitor of serine palmitoyltransferase, impacting sphingolipid synthesis. This can indirectly influence ZDHHC23 activity by modulating the availability of palmitoylation substrates and related lipid signaling pathways. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Cerulenin inhibits fatty acid synthase, affecting lipid synthesis and metabolism. This inhibition can indirectly enhance ZDHHC23 function by altering the balance of fatty acids and related substrates critical for its palmitoylation activity. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin, a HMG-CoA reductase inhibitor, impacts cholesterol synthesis. This can indirectly affect ZDHHC23 by altering the lipid environment, potentially enhancing its activity in protein palmitoylation. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate, through its action as a PPARα agonist, modulates lipid metabolism. This can lead to changes in fatty acid composition, indirectly enhancing ZDHHC23's palmitoylation activity by affecting the availability of substrates. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 inhibits neutral sphingomyelinase, altering sphingolipid metabolism. This can indirectly enhance ZDHHC23 activity by influencing the lipid environment and substrate availability for palmitoylation. | ||||||
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $187.00 $843.00 | 14 | |
Triacsin C inhibits acyl-CoA synthetase, impacting fatty acid metabolism. This inhibition may indirectly enhance ZDHHC23's function by modulating the availability of acyl groups necessary for its palmitoylation activity. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, as a NAD+ precursor, influences cellular redox states and energy metabolism. This can indirectly enhance ZDHHC23 activity by affecting the cellular metabolic environment, which is crucial for enzymatic activities like palmitoylation. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin, primarily used for glucose metabolism modulation, can indirectly enhance ZDHHC23 function. It does this by altering cellular energy states and potentially influencing lipid metabolism pathways that provide substrates for ZDHHC23's palmitoylation activity. | ||||||